Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tevogen Bio Holdings

0.9796
-0.0404-3.96%
Post-market: 0.98000.0004+0.04%19:58 EDT
Volume:536.91K
Turnover:521.30K
Market Cap:180.14M
PE:-13.99
High:1.03
Open:1.01
Low:0.9200
Close:1.02
Loading ...

Tevogen Bio Agrees With CD8 to Develop, Acquire Cell Therapy Production Facility

MT Newswires Live
·
18 Apr

Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility

THOMSON REUTERS
·
18 Apr

Press Release: Tevogen Bio Finalizes Agreement for Company's Own Cell Therapy Production Facility

Dow Jones
·
18 Apr

Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction

GlobeNewswire
·
16 Apr

Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald

GlobeNewswire
·
15 Apr

Tevogen announces Tevogen Generics following Trump’s tariff-related statements

TIPRANKS
·
10 Apr

Tevogen Bio Holdings: Announces Newest Effort, Tevogen Generics

THOMSON REUTERS
·
10 Apr

Tevogen Bio Holdings: Initiative Seeks to Expedite Domestic Manufacturing of Unbranded Pharmaceuticals & Apis in US

THOMSON REUTERS
·
10 Apr

Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission

GlobeNewswire
·
08 Apr

Tevogen Bio Holdings Delays Annual Report Filing

TIPRANKS
·
01 Apr

Press Release: Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan

Dow Jones
·
26 Mar

Tevogen Bio Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
11 Mar

Tevogen Bio Files New US Patent for T Cell Vaccine Under Development

MT Newswires Live
·
11 Mar

BRIEF-Tevogen Bio Announces Unique T Cell Vaccine Under Development & Files Patent With USPTO

Reuters
·
11 Mar

Tevogen announces new patent filed for T cell vaccine

TIPRANKS
·
11 Mar

Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent With the Uspto

THOMSON REUTERS
·
11 Mar

Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO

GlobeNewswire
·
11 Mar

Have Tevogen Bio Holdings Insiders Been Selling Stock?

Simply Wall St.
·
09 Mar

Tevogen Bio Holdings Initiated at Buy by D. Boral Capital

Dow Jones
·
04 Mar

BRIEF-Tevogen Bio To Receive $8 Mln Of Non-Dilutive Grant Funding

Reuters
·
04 Mar